| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.668 | 0.003 | 0.668 | Cathepsin L inhibitor | |||
| 0.655 | 0.002 | 0.655 | Cathepsin L1 inhibitor | |||
| 0.593 | 0 | 0.593 | HCV NS3/NS4A protease inhibitor | 0.052 0.029 DBMET00993 | ||
| 0.57 | 0.002 | 0.57 | Human rhinovirus A protease inhibitor | |||
| 0.427 | 0.002 | 0.427 | Cathepsin L2 inhibitor | |||
| 0.372 | 0.026 | 0.372 | Transcription factor STAT inhibitor | |||
| 0.331 | 0.005 | 0.331 | Protease inhibitor | |||
| 0.341 | 0.023 | 0.341 | Anticoagulant | |||
| 0.304 | 0.004 | 0.304 | Cathepsin B inhibitor | |||
| 0.291 | 0.011 | 0.291 | Proteasome inhibitor | |||
| 0.328 | 0.067 | 0.328 | Apoptosis antagonist | |||
| 0.246 | 0.003 | 0.246 | Cathepsin K inhibitor | |||
| 0.242 | 0.003 | 0.242 | Elastase 1 inhibitor | |||
| 0.359 | 0.134 | 0.359 | Apoptosis agonist | |||
| 0.242 | 0.028 | 0.242 | Thiol protease inhibitor | 0.126 0.103 DBMET00993 | ||
| 0.218 | 0.007 | 0.218 | Chymotrypsin inhibitor | |||
| 0.21 | 0.002 | 0.21 | HCV polyprotein inhibitor | 0.037 0.017 DBMET00993 | ||
| 0.289 | 0.089 | 0.289 | Immunomodulator | |||
| 0.247 | 0.067 | 0.247 | Calpain inhibitor | |||
| 0.18 | 0.004 | 0.18 | Caspase 9 inhibitor | |||
| 0.177 | 0.005 | 0.177 | Leukocyte elastase inhibitor | |||
| 0.191 | 0.04 | 0.191 | Neurotensin receptor agonist | 0.161 0.078 DBMET00993 | ||
| 0.143 | 0.011 | 0.143 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.124 | 0.009 | 0.124 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.121 | 0.014 | 0.121 | Cannabinoid CB1 receptor agonist | |||
| 0.123 | 0.017 | 0.123 | Thrombin inhibitor | |||
| 0.228 | 0.127 | 0.228 | Nootropic | |||
| 0.101 | 0.004 | 0.101 | Cathepsin S inhibitor | |||
| 0.103 | 0.009 | 0.103 | Elastase inhibitor | |||
| 0.232 | 0.142 | 0.288 | Antithrombotic | 0.288 0.097 DBMET00993 | DBMET00993 | |
| 0.09 | 0.003 | 0.09 | Baculoviral IAP repeat-containing protein inhibitor | |||
| 0.095 | 0.01 | 0.095 | Dipeptidyl peptidase inhibitor | |||
| 0.102 | 0.025 | 0.102 | Cannabinoid receptor agonist | |||
| 0.142 | 0.066 | 0.142 | Bone formation stimulant | |||
| 0.089 | 0.016 | 0.089 | Neurotensin receptor antagonist | |||
| 0.073 | 0.004 | 0.073 | Cathepsin F inhibitor | |||
| 0.201 | 0.132 | 0.201 | Transcription factor STAT3 inhibitor | |||
| 0.069 | 0.01 | 0.069 | Factor XIa inhibitor | 0.046 0.022 DBMET00993 | ||
| 0.064 | 0.008 | 0.064 | Caspase 2 inhibitor | |||
| 0.073 | 0.024 | 0.073 | Plasmin inhibitor | |||
| 0.052 | 0.005 | 0.052 | Calpain 1 inhibitor | |||
| 0.049 | 0.009 | 0.049 | Dipeptidyl peptidase I inhibitor | |||
| 0.049 | 0.01 | 0.049 | Factor XI inhibitor | |||
| 0.043 | 0.006 | 0.043 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.234 | 0.198 | 0.234 | Analgesic | |||
| 0.054 | 0.019 | 0.054 | Neuraminidase (Influenza A) inhibitor | 0.053 0.02 DBMET00993 | ||
| 0.093 | 0.06 | 0.093 | Falcipain inhibitor | |||
| 0.048 | 0.016 | 0.048 | Bradykinin antagonist | |||
| 0.035 | 0.004 | 0.035 | Baculoviral IAP repeat-containing protein 3 inhibitor | |||
| 0.214 | 0.185 | 0.214 | Toll-Like receptor agonist | |||
| 0.065 | 0.039 | 0.065 | Trypsin inhibitor | |||
| 0.087 | 0.062 | 0.087 | Falcipain 2 inhibitor | |||
| 0.03 | 0.009 | 0.03 | Elastase 2A inhibitor | |||
| 0.03 | 0.009 | 0.03 | Elastase 2 inhibitor | |||
| 0.038 | 0.017 | 0.038 | Bradykinin B2 receptor antagonist | |||
| 0.056 | 0.036 | 0.056 | Angiotensin-converting enzyme inhibitor | |||
| 0.045 | 0.027 | 0.045 | HIV-1 protease inhibitor | |||
| 0.075 | 0.057 | 0.075 | Somatostatin 1 agonist | |||
| 0.033 | 0.016 | 0.033 | Bradykinin B2 receptor agonist | |||
| 0.031 | 0.014 | 0.031 | HCV NS5A inhibitor | |||
| 0.044 | 0.03 | 0.044 | Dipeptidyl peptidase IV inhibitor | |||
| 0.014 | 0.004 | 0.014 | Baculoviral IAP repeat-containing protein 2 inhibitor | |||
| 0.12 | 0.11 | 0.151 | Thrombolytic | 0.151 0.081 DBMET00993 | DBMET00993 | |
| 0.078 | 0.07 | 0.078 | Factor XII inhibitor | |||
| 0.047 | 0.044 | 0.047 | Neuropeptide agonist | |||
| 0.027 | 0.025 | 0.027 | Peptide deformylase inhibitor | |||
| 0.201 | 0.2 | 0.201 | Toll-Like receptor 7 agonist | |||
| 0.084 | 0.083 | 0.104 | Interleukin 1 beta converting enzyme inhibitor | 0.104 0.052 DBMET00993 | DBMET00993 | |
| 0.014 | 0.013 | 0.014 | Dipeptidyl peptidase VIII inhibitor | |||
| 0.078 | 0.079 | 0.169 | Hematopoietic | 0.169 0.013 DBMET00993 | DBMET00993 | |
| 0.095 | 0.101 | 0.105 | Caspase 3 inhibitor | 0.105 0.083 DBMET00993 | DBMET00993 | |
| 0.124 | 0.14 | 0.154 | Angiogenesis stimulant | 0.154 0.12 DBMET00993 | DBMET00993 | |
| 0.042 | 0.069 | 0.084 | Bombesin 3 receptor antagonist | 0.084 0.018 DBMET00993 | DBMET00993 | |
| 0.041 | 0.07 | 0.064 | Neuraminidase inhibitor | 0.064 0.039 DBMET00993 | DBMET00993 | |
| 0.098 | 0.142 | 0.152 | Neurotrophic factor | 0.152 0.057 DBMET00993 | DBMET00993 | |
| 0.026 | 0.073 | 0.057 | Ribonucleoside-diphosphate reductase inhibitor | 0.057 0.036 DBMET00993 | DBMET00993 | |
| 0.024 | 0.078 | 0.058 | Ribonucleotide reductase inhibitor | 0.058 0.038 DBMET00993 | DBMET00993 | |
| 0.034 | 0.09 | 0.072 | Glucagon-like peptide 1 agonist | 0.072 0.04 DBMET00993 | DBMET00993 | |
| 0.045 | 0.103 | 0.075 | Neuraminidase (influenza) inhibitor | 0.075 0.029 DBMET00993 | DBMET00993 | |
| 0.095 | 0.174 | 0.156 | Psychostimulant | 0.156 0.111 DBMET00993 | DBMET00993 | |
| 0.056 | 0.141 | 0.088 | Falcipain 3 inhibitor | 0.088 0.083 DBMET00993 | DBMET00993 | |
| 0.027 | 0.122 | 0.069 | Farnesyltransferase inhibitor | 0.069 0.016 DBMET00993 | DBMET00993 | |
| 0.069 | 0.18 | 0.156 | Folate antagonist | 0.156 0.02 DBMET00993 | DBMET00993 | |
| 0.008 | 0.13 | 0.028 | Geranylgeranyltransferase I inhibitor | 0.028 0.009 DBMET00993 | DBMET00993 | |
| 0.007 | 0.156 | 0.062 | Bombesin agonist | 0.062 0.005 DBMET00993 | DBMET00993 | |
| 0.008 | 0.166 | 0.354 | AMPA 2 receptor antagonist | 0.354 0.002 DBMET00993 | DBMET00993 | |
| 0.088 | 0.246 | 0.163 | Immunostimulant | 0.163 0.144 DBMET00993 | DBMET00993 | |
| 0.08 | 0.24 | 0.174 | Interleukin antagonist | 0.174 0.1 DBMET00993 | DBMET00993 | |
| 0.011 | 0.178 | 0.031 | Calcitonin receptor agonist | 0.031 0.026 DBMET00993 | DBMET00993 | |
| 0.006 | 0.179 | 0.054 | Bombesin 3 receptor agonist | 0.054 0.005 DBMET00993 | DBMET00993 | |
| 0.057 | 0.242 | 0.11 | Cathepsin H inhibitor | 0.11 0.089 DBMET00993 | DBMET00993 | |
| 0.076 | 0.265 | 0.183 | Hemostatic | 0.183 0.04 DBMET00993 | DBMET00993 | |
| 0.004 | 0.201 | 0.052 | Arginase inhibitor | 0.052 0.014 DBMET00993 | DBMET00993 | |
| 0.107 | 0.333 | 0.196 | Neuropeptide Y2 antagonist | 0.196 0.127 DBMET00993 | DBMET00993 | |
| 0.004 | 0.236 | 0.029 | Angiotensin AT2 receptor antagonist | 0.029 0.013 DBMET00993 | DBMET00993 | |
| 0.011 | 0.25 | 0.036 | Carboxypeptidase B inhibitor | 0.036 0.018 DBMET00993 | DBMET00993 | |
| 0.013 | 0.26 | 0.026 | Glucosylceramidase stimulant | 0.026 0.024 DBMET00993 | DBMET00993 | |
| 0.005 | 0.285 | 0.025 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.025 0.024 DBMET00993 | DBMET00993 | |
| 0.022 | 0.313 | 0.051 | Bombesin 2 receptor antagonist | 0.051 0.032 DBMET00993 | DBMET00993 | |
| 0.055 | 0.355 | 0.131 | Platelet adhesion inhibitor | 0.131 0.13 DBMET00993 | DBMET00993 | |
| 0.006 | 0.325 | 0.021 | Neuraminidase (Influenza B) inhibitor | 0.021 0.015 DBMET00993 | DBMET00993 | |
| 0.023 | 0.344 | 0.074 | Potassium channel (Tandem pore domain) blocker | 0.074 0.05 DBMET00993 | DBMET00993 | |
| 0.021 | 0.362 | 0.12 | Histone deacetylase SIRT1 stimulant | 0.12 0.017 DBMET00993 | DBMET00993 | |
| 0.021 | 0.362 | 0.12 | Histone deacetylase stimulant | 0.12 0.017 DBMET00993 | DBMET00993 | |
| 0.046 | 0.388 | 0.287 | Platelet antagonist | 0.287 0.057 DBMET00993 | DBMET00993 | |
| 0.081 | 0.428 | 0.35 | Vasodilator, peripheral | 0.35 0.074 DBMET00993 | DBMET00993 | |
| 0.008 | 0.384 | 0.108 | Glutamate (mGluR) agonist | 0.108 0.021 DBMET00993 | DBMET00993 | |
| 0.079 | 0.463 | 0.343 | Insulysin inhibitor | 0.343 0.037 DBMET00993 | DBMET00993 | |
| 0.004 | 0.408 | 0.171 | Kainate receptor 4 antagonist | 0.171 0.003 DBMET00993 | DBMET00993 | |
| 0.063 | 0.472 | 0.152 | Lipocortins synthesis antagonist | 0.152 0.102 DBMET00993 | DBMET00993 | |
| 0.02 | 0.431 | 0.06 | Histone deacetylase SIRT3 inhibitor | 0.06 0.048 DBMET00993 | DBMET00993 | |
| 0.004 | 0.438 | 0.151 | Kainate receptor 3 antagonist | 0.151 0.003 DBMET00993 | DBMET00993 | |
| 0.035 | 0.47 | 0.094 | Glutamate (mGluR7) agonist | 0.094 0.073 DBMET00993 | DBMET00993 | |
| 0.097 | 0.536 | 0.293 | Antiinflammatory | 0.293 0.222 DBMET00993 | DBMET00993 | |
| 0.003 | 0.456 | 0.023 | Angiotensin AT1A receptor antagonist | 0.023 0.012 DBMET00993 | DBMET00993 | |
| 0.012 | 0.471 | 0.072 | Secretase beta inhibitor | 0.072 0.046 DBMET00993 | DBMET00993 | |
| 0.01 | 0.479 | 0.065 | Myc inhibitor | 0.065 0.024 DBMET00993 | DBMET00993 | |
| 0.065 | 0.535 | 0.214 | Sodium/bile acid cotransporter inhibitor | 0.214 0.17 DBMET00993 | DBMET00993 | |
| 0.003 | 0.48 | 0.254 | Kainate receptor 5 antagonist | 0.254 0.003 DBMET00993 | DBMET00993 | |
| 0.041 | 0.557 | 0.199 | NOS3 expression enhancer | 0.199 0.041 DBMET00993 | DBMET00993 | |
| 0.012 | 0.534 | 0.043 | Glutamate (mGluR8) antagonist | 0.043 0.013 DBMET00993 | DBMET00993 | |
| 0.006 | 0.534 | 0.089 | Glutamate (mGluR1a) antagonist | 0.089 0.006 DBMET00993 | DBMET00993 | |
| 0.011 | 0.558 | 0.159 | Nav1.8 sodium channel blocker | 0.159 0.012 DBMET00993 | DBMET00993 | |
| 0.009 | 0.557 | 0.125 | Glutamate (mGluR group I) antagonist | 0.125 0.018 DBMET00993 | DBMET00993 | |
| 0.009 | 0.558 | 0.086 | Carbonic anhydrase stimulant | 0.086 0.023 DBMET00993 | DBMET00993 | |
| 0.004 | 0.553 | 0.051 | Glutamate (mGluR5) agonist | 0.051 0.025 DBMET00993 | DBMET00993 | |
| 0.015 | 0.571 | 0.046 | CC chemokine receptor 2B antagonist | 0.046 0.041 DBMET00993 | DBMET00993 | |
| 0.004 | 0.561 | 0.099 | Protocollagen prolyl hydroxylase inhibitor | 0.099 0.004 DBMET00993 | DBMET00993 | |
| 0.004 | 0.561 | 0.065 | Glutamate (mGluR group I) agonist | 0.065 0.019 DBMET00993 | DBMET00993 | |
| 0.004 | 0.562 | 0.027 | Geranylgeranyltransferase inhibitor | 0.027 0.011 DBMET00993 | DBMET00993 | |
| 0.069 | 0.64 | 0.307 | Caspase 9 stimulant | 0.307 0.186 DBMET00993 | DBMET00993 | |
| 0.003 | 0.576 | 0.133 | AMPA 3 receptor antagonist | 0.133 0.004 DBMET00993 | DBMET00993 | |
| 0.002 | 0.578 | 0.031 | Lysine carboxypeptidase inhibitor | 0.031 0.015 DBMET00993 | DBMET00993 | |
| 0.009 | 0.585 | 0.117 | Aminopeptidase I inhibitor | 0.117 0.02 DBMET00993 | DBMET00993 | |
| 0.072 | 0.655 | 0.131 | CC chemokine 6 receptor antagonist | 0.131 0.067 DBMET00993 | DBMET00993 | |
| 0.005 | 0.59 | 0.07 | Glutamate (mGluR group II) agonist | 0.07 0.01 DBMET00993 | DBMET00993 | |
| 0.014 | 0.599 | 0.28 | Chelator | 0.28 0.013 DBMET00993 | DBMET00993 | |
| 0.007 | 0.595 | 0.111 | Maillard reaction inhibitor | 0.111 0.013 DBMET00993 | DBMET00993 | |
| 0.004 | 0.596 | 0.059 | Glutamate (mGluR2) agonist | 0.059 0.011 DBMET00993 | DBMET00993 | |
| 0.012 | 0.613 | 0.12 | Microtubule formation inhibitor | 0.12 0.061 DBMET00993 | DBMET00993 | |
| 0.02 | 0.638 | 0.164 | Insulin secretagoues | 0.164 0.061 DBMET00993 | DBMET00993 | |
| 0.006 | 0.626 | 0.18 | Glutamate (mGluR) antagonist | 0.18 0.012 DBMET00993 | DBMET00993 | |
| 0.004 | 0.625 | 0.074 | Neuronal nicotinic receptor antagonist | 0.074 0.042 DBMET00993 | DBMET00993 | |
| 0.003 | 0.633 | 0.03 | Purinergic P2Y15 antagonist | 0.03 0.018 DBMET00993 | DBMET00993 | |
| 0.004 | 0.637 | 0.217 | Glutamate receptor agonist | 0.217 0.009 DBMET00993 | DBMET00993 | |
| 0.005 | 0.641 | 0.055 | Membrane dipeptidase inhibitor | 0.055 0.013 DBMET00993 | DBMET00993 | |
| 0.009 | 0.646 | 0.058 | Fatty acid synthase inhibitor | 0.058 0.037 DBMET00993 | DBMET00993 | |
| 0.012 | 0.65 | 0.049 | Nicotinic alpha3beta2 receptor antagonist | 0.049 0.046 DBMET00993 | DBMET00993 | |
| 0.031 | 0.671 | 0.264 | Gastrin inhibitor | 0.264 0.064 DBMET00993 | DBMET00993 | |
| 0.026 | 0.67 | 0.172 | 3C-like protease (Human coronavirus) inhibitor | 0.172 0.072 DBMET00993 | DBMET00993 | |
| 0.002 | 0.648 | 0.027 | Nicotinic alpha4beta2 receptor agonist | 0.027 0.022 DBMET00993 | DBMET00993 | |
| 0.003 | 0.652 | 0.196 | Glutamate (mGluR1) antagonist | 0.196 0.005 DBMET00993 | DBMET00993 | |
| 0.019 | 0.679 | 0.148 | Lanosterol 14 alpha demethylase inhibitor | 0.148 0.012 DBMET00993 | DBMET00993 | |
| 0.004 | 0.675 | 0.078 | Acetylcholine nicotinic antagonist | 0.078 0.056 DBMET00993 | DBMET00993 | |
| 0.009 | 0.68 | 0.089 | Polo-like kinase-1 inhibitor | 0.089 0.063 DBMET00993 | DBMET00993 | |
| 0.003 | 0.676 | 0.047 | NMDA 2A receptor antagonist | 0.047 0.041 DBMET00993 | DBMET00993 | |
| 0.008 | 0.684 | 0.03 | DNA topoisomerase IV inhibitor | 0.03 0.02 DBMET00993 | DBMET00993 | |
| 0.009 | 0.686 | 0.068 | MAP-kinase-activated kinase 2 inhibitor | 0.068 0.062 DBMET00993 | DBMET00993 | |
| 0.001 | 0.681 | 0.159 | AMPA 1 receptor antagonist | 0.159 0.004 DBMET00993 | DBMET00993 | |
| 0.012 | 0.694 | 0.159 | Aminopeptidase B inhibitor | 0.159 0.034 DBMET00993 | DBMET00993 | |
| 0.007 | 0.689 | 0.027 | Hedgehog signaling activator | 0.027 0.019 DBMET00993 | DBMET00993 | |
| 0.004 | 0.688 | 0.043 | NMDA 2D receptor antagonist | 0.043 0.009 DBMET00993 | DBMET00993 | |
| 0.01 | 0.707 | 0.08 | MAP-kinase-activated kinase inhibitor | 0.08 0.063 DBMET00993 | DBMET00993 | |
| 0.002 | 0.701 | 0.038 | Methionyl aminopeptidase 1 inhibitor | 0.038 0.014 DBMET00993 | DBMET00993 | |
| 0.004 | 0.706 | 0.129 | Catalase inhibitor | 0.129 0.031 DBMET00993 | DBMET00993 | |
| 0.005 | 0.708 | 0.129 | DNA gyrase inhibitor | 0.129 0.011 DBMET00993 | DBMET00993 | |
| 0.01 | 0.724 | 0.086 | Prolactin inhibitor | 0.086 0.072 DBMET00993 | DBMET00993 | |
| 0.027 | 0.747 | 0.357 | Cyclophilin D inhibitor | 0.357 0.117 DBMET00993 | DBMET00993 | |
| 0.005 | 0.724 | 0.065 | HIV-1 integrase inhibitor | 0.065 0.056 DBMET00993 | DBMET00993 | |
| 0.007 | 0.728 | 0.069 | Phospholipase D inhibitor | 0.069 0.054 DBMET00993 | DBMET00993 | |
| 0.024 | 0.745 | 0.204 | Interleukin agonist | 0.204 0.117 DBMET00993 | DBMET00993 | |
| 0.009 | 0.738 | 0.116 | Acetylcholine M1 receptor antagonist | 0.116 0.115 DBMET00993 | DBMET00993 | |
| 0.001 | 0.742 | 0.031 | Nicotinic alpha3beta4 receptor agonist | 0.031 0.019 DBMET00993 | DBMET00993 | |
| 0.011 | 0.753 | 0.154 | Antiamyloidogenic | 0.154 0.142 DBMET00993 | DBMET00993 | |
| 0.013 | 0.757 | 0.151 | Adenylate cyclase stimulant | 0.151 0.061 DBMET00993 | DBMET00993 | |
| 0.015 | 0.759 | 0.464 | Antibacterial | 0.464 0.052 DBMET00993 | DBMET00993 | |
| 0.006 | 0.752 | 0.151 | Cholesterol synthesis inhibitor | 0.151 0.044 DBMET00993 | DBMET00993 | |
| 0.005 | 0.75 | 0.573 | Glutamate receptor antagonist | 0.573 0.004 DBMET00993 | DBMET00993 | |
| 0.015 | 0.762 | 0.161 | Cyclooxygenase 3 inhibitor | 0.161 0.04 DBMET00993 | DBMET00993 | |
| 0.012 | 0.761 | 0.148 | Acetylcholine release stimulant | 0.148 0.018 DBMET00993 | DBMET00993 | |
| 0.002 | 0.752 | 0.056 | Phosphorylase inhibitor | 0.056 0.027 DBMET00993 | DBMET00993 | |
| 0.003 | 0.753 | 0.051 | Histamine H1 receptor agonist | 0.051 0.017 DBMET00993 | DBMET00993 | |
| 0.003 | 0.755 | 0.082 | Nicotinic alpha4beta2 receptor antagonist | 0.082 0.048 DBMET00993 | DBMET00993 | |
| 0.001 | 0.753 | 0.025 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.025 0.021 DBMET00993 | DBMET00993 | |
| 0.002 | 0.757 | 0.081 | NMDA 2 receptor antagonist | 0.081 0.043 DBMET00993 | DBMET00993 | |
| 0.006 | 0.76 | 0.139 | Mucolytic | 0.139 0.039 DBMET00993 | DBMET00993 | |
| 0.004 | 0.76 | 0.105 | Alkylator | 0.105 0.083 DBMET00993 | DBMET00993 | |
| 0.003 | 0.761 | 0.021 | Retinoic acid beta receptor agonist | 0.021 0.011 DBMET00993 | DBMET00993 | |
| 0.005 | 0.766 | 0.105 | Expectorant | 0.105 0.063 DBMET00993 | DBMET00993 | |
| 0.003 | 0.774 | 0.052 | Histamine H2 receptor agonist | 0.052 0.02 DBMET00993 | DBMET00993 | |
| 0.002 | 0.774 | 0.14 | Retinoid X gamma receptor agonist | 0.14 0.003 DBMET00993 | DBMET00993 | |
| 0.001 | 0.775 | 0.021 | Angiotensin AT1B receptor antagonist | 0.021 0.005 DBMET00993 | DBMET00993 | |
| 0.015 | 0.79 | 0.061 | Adenine nucleotide translocase inhibitor | 0.061 0.026 DBMET00993 | DBMET00993 | |
| 0.01 | 0.786 | 0.383 | DNA synthesis inhibitor | 0.383 0.024 DBMET00993 | DBMET00993 | |
| 0.004 | 0.78 | 0.052 | Sphingosine 1-phosphate receptor 1 antagonist | 0.052 0.048 DBMET00993 | DBMET00993 | |
| 0.001 | 0.778 | 0.096 | Geranyltranstransferase inhibitor | 0.096 0.004 DBMET00993 | DBMET00993 | |
| 0.005 | 0.781 | 0.102 | Glutamate (mGluR group III) agonist | 0.102 0.01 DBMET00993 | DBMET00993 | |
| 0.005 | 0.788 | 0.212 | Anticonvulsant | 0.212 0.075 DBMET00993 | DBMET00993 | |
| 0.002 | 0.788 | 0.049 | Angiotensin II receptor antagonist | 0.049 0.007 DBMET00993 | DBMET00993 | |
| 0.019 | 0.808 | 0.545 | Superoxide dismutase inhibitor | 0.545 0.009 DBMET00993 | DBMET00993 | |
| 0.01 | 0.805 | 0.286 | Cell wall synthesis inhibitor | 0.286 0.011 DBMET00993 | DBMET00993 | |
| 0.004 | 0.8 | 0.169 | Diuretic | 0.169 0.061 DBMET00993 | DBMET00993 | |
| 0.001 | 0.799 | 0.044 | Antimetabolite | 0.044 0.036 DBMET00993 | DBMET00993 | |
| 0.039 | 0.839 | 0.156 | Heat shock protein 70 antagonist | 0.156 0.034 DBMET00993 | DBMET00993 | |
| 0.006 | 0.806 | 0.098 | Aminoacyl-tRNA synthetase inhibitor | 0.098 0.048 DBMET00993 | DBMET00993 | |
| 0.003 | 0.804 | 0.041 | Glutamate (mGluR3) agonist | 0.041 0.009 DBMET00993 | DBMET00993 | |
| 0.003 | 0.806 | 0.13 | AMPA 4 receptor antagonist | 0.13 0.004 DBMET00993 | DBMET00993 | |
| 0.004 | 0.812 | 0.061 | Alpha-mannosidase inhibitor | 0.061 0.026 DBMET00993 | DBMET00993 | |
| 0.003 | 0.812 | 0.023 | Retinoic acid receptor agonist | 0.023 0.015 DBMET00993 | DBMET00993 | |
| 0.003 | 0.819 | 0.162 | Phospholipase A2 inhibitor | 0.162 0.064 DBMET00993 | DBMET00993 | |
| 0.027 | 0.845 | 0.19 | MAP-kinase-activated kinase 5 inhibitor | 0.19 0.116 DBMET00993 | DBMET00993 | |
| 0.003 | 0.821 | 0.022 | Retinoic acid gamma receptor agonist | 0.022 0.017 DBMET00993 | DBMET00993 | |
| 0.001 | 0.821 | 0.014 | Egl nine homolog 2 inhibitor | 0.014 0.006 DBMET00993 | DBMET00993 | |
| 0.009 | 0.832 | 0.186 | Interleukin 1 antagonist | 0.186 0.039 DBMET00993 | DBMET00993 | |
| 0.003 | 0.827 | 0.056 | Sphingosine 1-phosphate receptor 3 antagonist | 0.056 0.044 DBMET00993 | DBMET00993 | |
| 0.009 | 0.834 | 0.123 | Anabolic | 0.123 0.037 DBMET00993 | DBMET00993 | |
| 0.005 | 0.831 | 0.116 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.116 0.112 DBMET00993 | DBMET00993 | |
| 0.002 | 0.828 | 0.069 | LFA antagonist | 0.069 0.004 DBMET00993 | DBMET00993 | |
| 0.017 | 0.845 | 0.144 | Interleukin 4 antagonist | 0.144 0.055 DBMET00993 | DBMET00993 | |
| 0.003 | 0.831 | 0.066 | Diacylglycerol O-acyltransferase inhibitor | 0.066 0.022 DBMET00993 | DBMET00993 | |
| 0.01 | 0.838 | 0.23 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.23 0.012 DBMET00993 | DBMET00993 | |
| 0.005 | 0.834 | 0.653 | GABA C receptor agonist | 0.653 0.002 DBMET00993 | DBMET00993 | |
| 0.003 | 0.836 | 0.037 | Glutamate (mGluR1) agonist | 0.037 0.006 DBMET00993 | DBMET00993 | |
| 0.002 | 0.837 | 0.087 | Retinoid X beta receptor agonist | 0.087 0.004 DBMET00993 | DBMET00993 | |
| 0.014 | 0.85 | 0.11 | Interleukin 1b antagonist | 0.11 0.07 DBMET00993 | DBMET00993 | |
| 0 | 0.837 | 0.051 | Kainate receptor 1 antagonist | 0.051 0.005 DBMET00993 | DBMET00993 | |
| 0.04 | 0.878 | 0.276 | 5 Hydroxytryptamine uptake stimulant | 0.276 0.059 DBMET00993 | DBMET00993 | |
| 0.006 | 0.847 | 0.133 | Pregnane X receptor agonist | 0.133 0.09 DBMET00993 | DBMET00993 | |
| 0.006 | 0.848 | 0.543 | Alpha-N-acetylglucosaminidase inhibitor | 0.543 0.004 DBMET00993 | DBMET00993 | |
| 0.056 | 0.899 | 0.349 | Calcium channel L-type activator | 0.349 0.118 DBMET00993 | DBMET00993 | |
| 0.001 | 0.844 | 0.148 | Ornithine carbamoyltransferase inhibitor | 0.148 0.01 DBMET00993 | DBMET00993 | |
| 0.001 | 0.846 | 0.024 | Vanilloid 2 agonist | 0.024 0.02 DBMET00993 | DBMET00993 | |
| 0.012 | 0.86 | 0.188 | Phospholipase C inhibitor | 0.188 0.053 DBMET00993 | DBMET00993 | |
| 0.013 | 0.864 | 0.322 | Hypoglycemic | 0.322 0.046 DBMET00993 | DBMET00993 | |
| 0.002 | 0.854 | 0.021 | Retinoic acid alpha receptor antagonist | 0.021 0.013 DBMET00993 | DBMET00993 | |
| 0.001 | 0.855 | 0.109 | NMDA receptor subunit 3A antagonist | 0.109 0.008 DBMET00993 | DBMET00993 | |
| 0.001 | 0.857 | 0.058 | Angiotensin AT1 receptor antagonist | 0.058 0.008 DBMET00993 | DBMET00993 | |
| 0.006 | 0.867 | 0.181 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.181 0.091 DBMET00993 | DBMET00993 | |
| 0.004 | 0.864 | 0.167 | Clk dual-specificity kinase inhibitor | 0.167 0.1 DBMET00993 | DBMET00993 | |
| 0.003 | 0.864 | 0.059 | Kainate receptor agonist | 0.059 0.007 DBMET00993 | DBMET00993 | |
| 0.001 | 0.863 | 0.024 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.019 DBMET00993 | DBMET00993 | |
| 0.009 | 0.871 | 0.665 | Cholesterol antagonist | 0.665 0.011 DBMET00993 | DBMET00993 | |
| 0.003 | 0.866 | 0.306 | Nicotinic acid receptor 2 agonist | 0.306 0.003 DBMET00993 | DBMET00993 | |
| 0.003 | 0.866 | 0.029 | Retinoid X gamma receptor antagonist | 0.029 0.015 DBMET00993 | DBMET00993 | |
| 0.005 | 0.87 | 0.213 | GABA C receptor rho-1 antagonist | 0.213 0.006 DBMET00993 | DBMET00993 | |
| 0.003 | 0.869 | 0.071 | Sphingosine 1-phosphate receptor antagonist | 0.071 0.068 DBMET00993 | DBMET00993 | |
| 0 | 0.867 | 0.037 | Nicotinic acid receptor 1 antagonist | 0.037 0.004 DBMET00993 | DBMET00993 | |
| 0.002 | 0.87 | 0.053 | Mannosidase inhibitor | 0.053 0.022 DBMET00993 | DBMET00993 | |
| 0 | 0.868 | 0.015 | Glutamate (mGluR6) agonist | 0.015 0.006 DBMET00993 | DBMET00993 | |
| 0.005 | 0.874 | 0.124 | Ornithine decarboxylase inhibitor | 0.124 0.023 DBMET00993 | DBMET00993 | |
| 0.002 | 0.873 | 0.085 | Na+ K+ transporting ATPase inhibitor | 0.085 0.045 DBMET00993 | DBMET00993 | |
| 0.001 | 0.874 | 0.163 | Argininosuccinate synthase inhibitor | 0.163 0.01 DBMET00993 | DBMET00993 | |
| 0.002 | 0.876 | 0.188 | NMDA receptor antagonist | 0.188 0.016 DBMET00993 | DBMET00993 | |
| 0.001 | 0.875 | 0.135 | NMDA receptor subunit 3B antagonist | 0.135 0.007 DBMET00993 | DBMET00993 | |
| 0.004 | 0.884 | 0.198 | Mcl-1 antagonist | 0.198 0.057 DBMET00993 | DBMET00993 | |
| 0.028 | 0.909 | 0.202 | 5 Hydroxytryptamine release stimulant | 0.202 0.119 DBMET00993 | DBMET00993 | |
| 0.015 | 0.896 | 0.669 | 5 Hydroxytryptamine release inhibitor | 0.669 0.005 DBMET00993 | DBMET00993 | |
| 0.003 | 0.885 | 0.072 | Pregnane X receptor antagonist | 0.072 0.012 DBMET00993 | DBMET00993 | |
| 0.037 | 0.919 | 0.18 | 5 Hydroxytryptamine 3E antagonist | 0.18 0.104 DBMET00993 | DBMET00993 | |
| 0.004 | 0.886 | 0.209 | GABA C receptor antagonist | 0.209 0.011 DBMET00993 | DBMET00993 | |
| 0.001 | 0.884 | 0.127 | Kainate receptor antagonist | 0.127 0.005 DBMET00993 | DBMET00993 | |
| 0.001 | 0.884 | 0.038 | Glutamate (mGluR1a) agonist | 0.038 0.006 DBMET00993 | DBMET00993 | |
| 0.003 | 0.888 | 0.092 | Glycine receptor antagonist | 0.092 0.04 DBMET00993 | DBMET00993 | |
| 0.005 | 0.89 | 0.111 | Glutamate (mGluR6) antagonist | 0.111 0.007 DBMET00993 | DBMET00993 | |
| 0.001 | 0.887 | 0.118 | Kainate receptor 2 antagonist | 0.118 0.004 DBMET00993 | DBMET00993 | |
| 0.001 | 0.888 | 0.063 | Glutamate (mGluR2) antagonist | 0.063 0.005 DBMET00993 | DBMET00993 | |
| 0.002 | 0.892 | 0.022 | Retinoic acid receptor antagonist | 0.022 0.009 DBMET00993 | DBMET00993 | |
| 0.003 | 0.894 | 0.059 | Interferon inducer | 0.059 0.055 DBMET00993 | DBMET00993 | |
| 0.006 | 0.897 | 0.083 | Sphingomyelinase inhibitor | 0.083 0.082 DBMET00993 | DBMET00993 | |
| 0.007 | 0.898 | 0.098 | Bile acid receptor antagonist | 0.098 0.054 DBMET00993 | DBMET00993 | |
| 0.002 | 0.895 | 0.039 | Integrin alpha2 antagonist | 0.039 0.022 DBMET00993 | DBMET00993 | |
| 0.001 | 0.896 | 0.089 | Glutamate (mGluR group II) antagonist | 0.089 0.005 DBMET00993 | DBMET00993 | |
| 0.009 | 0.905 | 0.31 | Vasodilator, coronary | 0.31 0.079 DBMET00993 | DBMET00993 | |
| 0.002 | 0.897 | 0.05 | Dihydroorotase inhibitor | 0.05 0.024 DBMET00993 | DBMET00993 | |
| 0.008 | 0.904 | 0.133 | HIV-1 integrase (Overall Integration) inhibitor | 0.133 0.033 DBMET00993 | DBMET00993 | |
| 0.001 | 0.898 | 0.204 | AMPA receptor antagonist | 0.204 0.004 DBMET00993 | DBMET00993 | |
| 0.007 | 0.904 | 0.1 | TRPA1 agonist | 0.1 0.088 DBMET00993 | DBMET00993 | |
| 0.007 | 0.906 | 0.132 | Melanin inhibitor | 0.132 0.111 DBMET00993 | DBMET00993 | |
| 0.004 | 0.904 | 0.093 | Glutamate (mGluR4) antagonist | 0.093 0.006 DBMET00993 | DBMET00993 | |
| 0.002 | 0.903 | 0.049 | Beta 2 adrenoreceptor antagonist | 0.049 0.038 DBMET00993 | DBMET00993 | |
| 0.002 | 0.903 | 0.043 | Beta adrenoreceptor agonist | 0.043 0.041 DBMET00993 | DBMET00993 | |
| 0.001 | 0.903 | 0.149 | Acyl-CoA dehydrogenase inhibitor | 0.149 0.009 DBMET00993 | DBMET00993 | |
| 0.002 | 0.905 | 0.07 | Lysophosphatidic acid 3 receptor antagonist | 0.07 0.014 DBMET00993 | DBMET00993 | |
| 0.003 | 0.907 | 0.06 | AICAR transformylase inhibitor | 0.06 0.014 DBMET00993 | DBMET00993 | |
| 0.027 | 0.931 | 0.516 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.516 0.027 DBMET00993 | DBMET00993 | |
| 0.001 | 0.905 | 0.048 | GABA uptake inhibitor | 0.048 0.017 DBMET00993 | DBMET00993 | |
| 0.001 | 0.907 | 0.086 | Pim-3 kinase inhibitor | 0.086 0.065 DBMET00993 | DBMET00993 | |
| 0.007 | 0.913 | 0.159 | ATPase inhibitor | 0.159 0.087 DBMET00993 | DBMET00993 | |
| 0.002 | 0.908 | 0.061 | Beta adrenoreceptor antagonist | 0.061 0.054 DBMET00993 | DBMET00993 | |
| 0.004 | 0.911 | 0.104 | Toll-Like receptor 2 antagonist | 0.104 0.099 DBMET00993 | DBMET00993 | |
| 0.002 | 0.91 | 0.045 | Tryptophan 5 hydroxylase inhibitor | 0.045 0.008 DBMET00993 | DBMET00993 | |
| 0.002 | 0.911 | 0.082 | Inducible nitric-oxide synthase inhibitor | 0.082 0.059 DBMET00993 | DBMET00993 | |
| 0.002 | 0.911 | 0.025 | ICAM 1 antagonist | 0.025 0.012 DBMET00993 | DBMET00993 | |
| 0.001 | 0.912 | 0.063 | Thromboxane A2 antagonist | 0.063 0.026 DBMET00993 | DBMET00993 | |
| 0.001 | 0.913 | 0.011 | Retinoic acid beta receptor antagonist | 0.011 0.009 DBMET00993 | DBMET00993 | |
| 0.005 | 0.916 | 0.104 | Topoisomerase II inhibitor | 0.104 0.082 DBMET00993 | DBMET00993 | |
| 0.003 | 0.915 | 0.069 | Glutamate (mGluR8) agonist | 0.069 0.005 DBMET00993 | DBMET00993 | |
| 0.003 | 0.915 | 0.061 | Phosphodiesterase 1C inhibitor | 0.061 0.046 DBMET00993 | DBMET00993 | |
| 0.004 | 0.917 | 0.214 | CDC-like kinase 1 inhibitor | 0.214 0.029 DBMET00993 | DBMET00993 | |
| 0.004 | 0.918 | 0.24 | Transcription factor NF kappa B inhibitor | 0.24 0.135 DBMET00993 | DBMET00993 | |
| 0.003 | 0.917 | 0.286 | Prostaglandin E2 antagonist | 0.286 0.004 DBMET00993 | DBMET00993 | |
| 0.001 | 0.915 | 0.079 | Glutamate (mGluR3) antagonist | 0.079 0.005 DBMET00993 | DBMET00993 | |
| 0.002 | 0.917 | 0.134 | NMDA receptor agonist | 0.134 0.01 DBMET00993 | DBMET00993 | |
| 0.008 | 0.923 | 0.144 | MAP kinase 3 inhibitor | 0.144 0.077 DBMET00993 | DBMET00993 | |
| 0.001 | 0.917 | 0.061 | Aryl hydrocarbon receptor antagonist | 0.061 0.051 DBMET00993 | DBMET00993 | |
| 0.001 | 0.917 | 0.012 | Retinoic acid receptor gamma antagonist | 0.012 0.008 DBMET00993 | DBMET00993 | |
| 0.001 | 0.917 | 0.027 | Lysophosphatidic acid 1 receptor antagonist | 0.027 0.008 DBMET00993 | DBMET00993 | |
| 0.01 | 0.927 | 0.191 | Interferon gamma antagonist | 0.191 0.044 DBMET00993 | DBMET00993 | |
| 0.005 | 0.922 | 0.213 | Glutamate dehydrogenase inhibitor | 0.213 0.009 DBMET00993 | DBMET00993 | |
| 0.001 | 0.919 | 0.038 | Carnitine palmitoyltransferase inhibitor | 0.038 0.018 DBMET00993 | DBMET00993 | |
| 0.001 | 0.919 | 0.215 | Phosphofructokinase-1 inhibitor | 0.215 0.01 DBMET00993 | DBMET00993 | |
| 0.003 | 0.921 | 0.197 | Arachidonic acid antagonist | 0.197 0.035 DBMET00993 | DBMET00993 | |
| 0.003 | 0.921 | 0.139 | Cyclin-dependent kinase 8 inhibitor | 0.139 0.092 DBMET00993 | DBMET00993 | |
| 0.006 | 0.925 | 0.207 | Neurotrophic factor enhancer | 0.207 0.07 DBMET00993 | DBMET00993 | |
| 0.001 | 0.921 | 0.075 | Thromboxane antagonist | 0.075 0.023 DBMET00993 | DBMET00993 | |
| 0.003 | 0.923 | 0.195 | Prostaglandin antagonist | 0.195 0.007 DBMET00993 | DBMET00993 | |
| 0.006 | 0.926 | 0.135 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.135 0.019 DBMET00993 | DBMET00993 | |
| 0.001 | 0.922 | 0.14 | Carbamoyl phosphate synthetase inhibitor | 0.14 0.012 DBMET00993 | DBMET00993 | |
| 0.001 | 0.923 | 0.031 | MAP3K8 inhibitor | 0.031 0.015 DBMET00993 | DBMET00993 | |
| 0.003 | 0.928 | 0.25 | Dyrk kinase inhibitor | 0.25 0.072 DBMET00993 | DBMET00993 | |
| 0.003 | 0.928 | 0.051 | Retinoic acid alpha receptor agonist | 0.051 0.014 DBMET00993 | DBMET00993 | |
| 0.009 | 0.934 | 0.287 | Adenylate kinase inhibitor | 0.287 0.008 DBMET00993 | DBMET00993 | |
| 0.001 | 0.927 | 0.041 | Protein kinase (CK2) beta inhibitor | 0.041 0.012 DBMET00993 | DBMET00993 | |
| 0.008 | 0.933 | 0.148 | Histone acetyltransferase inhibitor | 0.148 0.142 DBMET00993 | DBMET00993 | |
| 0.004 | 0.93 | 0.446 | Uric acid excretion stimulant | 0.446 0.004 DBMET00993 | DBMET00993 | |
| 0.001 | 0.927 | 0.038 | Carnitine palmitoyltransferase 1 inhibitor | 0.038 0.018 DBMET00993 | DBMET00993 | |
| 0.003 | 0.93 | 0.259 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.259 0.064 DBMET00993 | DBMET00993 | |
| 0.002 | 0.928 | 0.084 | Thromboxane synthase inhibitor | 0.084 0.01 DBMET00993 | DBMET00993 | |
| 0.008 | 0.935 | 0.172 | CF transmembrane conductance regulator agonist | 0.172 0.044 DBMET00993 | DBMET00993 | |
| 0.004 | 0.931 | 0.084 | MAP kinase kinase 7 inhibitor | 0.084 0.035 DBMET00993 | DBMET00993 | |
| 0.001 | 0.928 | 0.02 | Methylmalonyl-CoA mutase inhibitor | 0.02 0.008 DBMET00993 | DBMET00993 | |
| 0.01 | 0.937 | 0.517 | GABA C receptor rho-3 antagonist | 0.517 0.022 DBMET00993 | DBMET00993 | |
| 0.004 | 0.934 | 0.089 | MDM2 inhibitor | 0.089 0.012 DBMET00993 | DBMET00993 | |
| 0.001 | 0.932 | 0.429 | Histidine decarboxylase inhibitor | 0.429 0.004 DBMET00993 | DBMET00993 | |
| 0.001 | 0.931 | 0.074 | Nicotinic acid receptor 2 antagonist | 0.074 0.003 DBMET00993 | DBMET00993 | |
| 0.001 | 0.931 | 0.051 | Alpha 1d adrenoreceptor agonist | 0.051 0.016 DBMET00993 | DBMET00993 | |
| 0.001 | 0.933 | 0.029 | Integrin alpha2beta1 antagonist | 0.029 0.014 DBMET00993 | DBMET00993 | |
| 0.003 | 0.935 | 0.067 | Adenosine deaminase inhibitor | 0.067 0.015 DBMET00993 | DBMET00993 | |
| 0.001 | 0.933 | 0.064 | Prostaglandin-E synthase inhibitor | 0.064 0.057 DBMET00993 | DBMET00993 | |
| 0.001 | 0.933 | 0.055 | DNA gyrase subunit B inhibitor | 0.055 0.01 DBMET00993 | DBMET00993 | |
| 0.001 | 0.934 | 0.036 | TRPM8 blocker | 0.036 0.029 DBMET00993 | DBMET00993 | |
| 0.001 | 0.935 | 0.327 | Aconitate hydratase inhibitor | 0.327 0.002 DBMET00993 | DBMET00993 | |
| 0.001 | 0.935 | 0.055 | Glutamate (mGluR4) agonist | 0.055 0.009 DBMET00993 | DBMET00993 | |
| 0.002 | 0.936 | 0.085 | Adrenaline agonist | 0.085 0.052 DBMET00993 | DBMET00993 | |
| 0.001 | 0.936 | 0.041 | GABA B receptor antagonist | 0.041 0.033 DBMET00993 | DBMET00993 | |
| 0.014 | 0.949 | 0.257 | Tyrosine 3 hydroxylase inhibitor | 0.257 0.062 DBMET00993 | DBMET00993 | |
| 0.002 | 0.937 | 0.212 | I kappa B kinase epsilon inhibitor | 0.212 0.061 DBMET00993 | DBMET00993 | |
| 0.004 | 0.939 | 0.088 | Glycine receptor agonist | 0.088 0.03 DBMET00993 | DBMET00993 | |
| 0.001 | 0.937 | 0.658 | Porphobilinogen synthase inhibitor | 0.658 0.003 DBMET00993 | DBMET00993 | |
| 0 | 0.937 | 0.026 | Prostaglandin EP2 agonist | 0.026 0.014 DBMET00993 | DBMET00993 | |
| 0.001 | 0.938 | 0.062 | Beta 1 adrenoreceptor antagonist | 0.062 0.034 DBMET00993 | DBMET00993 | |
| 0.001 | 0.937 | 0.019 | Hexokinase stimulant | 0.019 0.015 DBMET00993 | DBMET00993 | |
| 0.001 | 0.938 | 0.046 | Thymidylate synthase inhibitor | 0.046 0.033 DBMET00993 | DBMET00993 | |
| 0 | 0.938 | 0.038 | Egl nine homolog 1 inhibitor | 0.038 0.004 DBMET00993 | DBMET00993 | |
| 0.001 | 0.94 | 0.048 | Oleamide hydrolase inhibitor | 0.048 0.029 DBMET00993 | DBMET00993 | |
| 0.013 | 0.952 | 0.719 | Histamine release inhibitor | 0.719 0.004 DBMET00993 | DBMET00993 | |
| 0.002 | 0.941 | 0.103 | GABA A receptor agonist | 0.103 0.035 DBMET00993 | DBMET00993 | |
| 0.002 | 0.941 | 0.307 | Alcohol dehydrogenase inhibitor | 0.307 0.005 DBMET00993 | DBMET00993 | |
| 0.003 | 0.943 | 0.29 | Succinate dehydrogenase inhibitor | 0.29 0.012 DBMET00993 | DBMET00993 | |
| 0 | 0.94 | 0.041 | Prostaglandin H2 antagonist | 0.041 0.005 DBMET00993 | DBMET00993 | |
| 0.001 | 0.941 | 0.148 | LIM domain kinase 1 inhibitor | 0.148 0.1 DBMET00993 | DBMET00993 | |
| 0 | 0.941 | 0.019 | Carbonic anhydrase X inhibitor | 0.019 0.009 DBMET00993 | DBMET00993 | |
| 0 | 0.941 | 0.019 | Carbonic anhydrase VIII inhibitor | 0.019 0.009 DBMET00993 | DBMET00993 | |
| 0.003 | 0.944 | 0.223 | Keratolytic | 0.223 0.007 DBMET00993 | DBMET00993 | |
| 0.004 | 0.946 | 0.114 | Sphingosine 1-phosphate receptor 4 antagonist | 0.114 0.084 DBMET00993 | DBMET00993 | |
| 0.002 | 0.943 | 0.108 | CYP2A6 inhibitor | 0.108 0.032 DBMET00993 | DBMET00993 | |
| 0.004 | 0.946 | 0.241 | GABA C receptor rho-2 antagonist | 0.241 0.014 DBMET00993 | DBMET00993 | |
| 0.003 | 0.946 | 0.071 | Plasminogen activator inhibitor antagonist | 0.071 0.018 DBMET00993 | DBMET00993 | |
| 0.003 | 0.945 | 0.203 | Insulin sensitizer | 0.203 0.07 DBMET00993 | DBMET00993 | |
| 0.002 | 0.945 | 0.083 | Protein kinase C beta inhibitor | 0.083 0.026 DBMET00993 | DBMET00993 | |
| 0.001 | 0.944 | 0.091 | Nerve growth factor antagonist | 0.091 0.003 DBMET00993 | DBMET00993 | |
| 0.002 | 0.945 | 0.076 | Glucose-6-phosphate isomerase inhibitor | 0.076 0.01 DBMET00993 | DBMET00993 | |
| 0.005 | 0.95 | 0.093 | Exportin-1 inhibitor | 0.093 0.013 DBMET00993 | DBMET00993 | |
| 0.001 | 0.945 | 0.05 | Stearoyl-CoA desaturase inhibitor | 0.05 0.023 DBMET00993 | DBMET00993 | |
| 0.001 | 0.946 | 0.22 | Glutamate decarboxylase inhibitor | 0.22 0.005 DBMET00993 | DBMET00993 | |
| 0.004 | 0.949 | 0.172 | Cytokine production inhibitor | 0.172 0.048 DBMET00993 | DBMET00993 | |
| 0.002 | 0.948 | 0.114 | Protein kinase C gamma inhibitor | 0.114 0.058 DBMET00993 | DBMET00993 | |
| 0.005 | 0.952 | 0.126 | Interleukin 8 antagonist | 0.126 0.054 DBMET00993 | DBMET00993 | |
| 0.003 | 0.95 | 0.151 | Sphingosine 1-phosphate receptor 5 antagonist | 0.151 0.059 DBMET00993 | DBMET00993 | |
| 0.001 | 0.948 | 0.068 | Farnesoid X receptor agonist | 0.068 0.008 DBMET00993 | DBMET00993 | |
| 0.001 | 0.949 | 0.108 | Glutamate (mGluR7) antagonist | 0.108 0.007 DBMET00993 | DBMET00993 | |
| 0.002 | 0.95 | 0.079 | Glutamate (mGluR group III) antagonist | 0.079 0.008 DBMET00993 | DBMET00993 | |
| 0.01 | 0.959 | 0.138 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.138 0.098 DBMET00993 | DBMET00993 | |
| 0.001 | 0.95 | 0.032 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.032 0.027 DBMET00993 | DBMET00993 | |
| 0.003 | 0.953 | 0.114 | Granulocyte macrophage colony stimulating factor agonist | 0.114 0.02 DBMET00993 | DBMET00993 | |
| 0.005 | 0.954 | 0.243 | Antibacterial (Helicobacter pylori) | 0.243 0.013 DBMET00993 | DBMET00993 | |
| 0.001 | 0.95 | 0.038 | Leukotriene C4 antagonist | 0.038 0.031 DBMET00993 | DBMET00993 | |
| 0.001 | 0.951 | 0.06 | Leukotriene C antagonist | 0.06 0.03 DBMET00993 | DBMET00993 | |
| 0.002 | 0.952 | 0.132 | Urease inhibitor | 0.132 0.035 DBMET00993 | DBMET00993 | |
| 0.001 | 0.952 | 0.073 | Dihydroorotate dehydrogenase inhibitor | 0.073 0.02 DBMET00993 | DBMET00993 | |
| 0.004 | 0.955 | 0.091 | mTOR complex 2 inhibitor | 0.091 0.046 DBMET00993 | DBMET00993 | |
| 0.008 | 0.959 | 0.136 | Photosensitizer | 0.136 0.041 DBMET00993 | DBMET00993 | |
| 0.002 | 0.955 | 0.044 | Heme oxygenase inhibitor | 0.044 0.027 DBMET00993 | DBMET00993 | |
| 0.001 | 0.954 | 0.196 | Protein kinase (CK2) inhibitor | 0.196 0.019 DBMET00993 | DBMET00993 | |
| 0.001 | 0.954 | 0.027 | Methionyl aminopeptidase 2 inhibitor | 0.027 0.016 DBMET00993 | DBMET00993 | |
| 0.003 | 0.956 | 0.203 | DOPA decarboxylase inhibitor | 0.203 0.006 DBMET00993 | DBMET00993 | |
| 0.003 | 0.957 | 0.045 | Purinergic P2Y14 antagonist | 0.045 0.009 DBMET00993 | DBMET00993 | |
| 0 | 0.954 | 0.033 | NMDA receptor glycine site antagonist | 0.033 0.011 DBMET00993 | DBMET00993 | |
| 0.016 | 0.97 | 0.106 | Glutamate release inhibitor | 0.106 0.035 DBMET00993 | DBMET00993 | |
| 0.008 | 0.962 | 0.177 | Ca2+-transporting ATPase inhibitor | 0.177 0.008 DBMET00993 | DBMET00993 | |
| 0.001 | 0.955 | 0.069 | Peroxisome proliferator-activated receptor gamma antagonist | 0.069 0.055 DBMET00993 | DBMET00993 | |
| 0.001 | 0.956 | 0.108 | Dopamine beta hydroxylase inhibitor | 0.108 0.004 DBMET00993 | DBMET00993 | |
| 0.002 | 0.957 | 0.115 | Sphingosine 1-phosphate receptor 2 antagonist | 0.115 0.111 DBMET00993 | DBMET00993 | |
| 0.001 | 0.957 | 0.219 | Protein kinase (CK2) alpha inhibitor | 0.219 0.021 DBMET00993 | DBMET00993 | |
| 0.002 | 0.959 | 0.13 | Beta amyloid protein antagonist | 0.13 0.058 DBMET00993 | DBMET00993 | |
| 0 | 0.957 | 0.023 | Retinoid X beta receptor antagonist | 0.023 0.009 DBMET00993 | DBMET00993 | |
| 0.001 | 0.958 | 0.092 | GABA aminotransferase inhibitor | 0.092 0.033 DBMET00993 | DBMET00993 | |
| 0.02 | 0.977 | 0.256 | Nitric-oxide synthase stimulant | 0.256 0.028 DBMET00993 | DBMET00993 | |
| 0.001 | 0.958 | 0.047 | Sphingosine 1-phosphate receptor 1 agonist | 0.047 0.023 DBMET00993 | DBMET00993 | |
| 0 | 0.959 | 0.071 | Guanylate cyclase inhibitor | 0.071 0.005 DBMET00993 | DBMET00993 | |
| 0.002 | 0.96 | 0.161 | GABA receptor agonist | 0.161 0.03 DBMET00993 | DBMET00993 | |
| 0.001 | 0.96 | 0.049 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.049 0.044 DBMET00993 | DBMET00993 | |
| 0 | 0.959 | 0.024 | CC chemokine 9 receptor antagonist | 0.024 0.005 DBMET00993 | DBMET00993 | |
| 0.002 | 0.961 | 0.082 | Dihydroorotate oxidase inhibitor | 0.082 0.009 DBMET00993 | DBMET00993 | |
| 0.002 | 0.961 | 0.12 | Histamine N-methyltransferase inhibitor | 0.12 0.03 DBMET00993 | DBMET00993 | |
| 0.006 | 0.965 | 0.079 | Estrogen-related receptor beta agonist | 0.079 0.069 DBMET00993 | DBMET00993 | |
| 0.001 | 0.96 | 0.058 | Potassium channel intermediate-conductance Ca-activated blocker | 0.058 0.045 DBMET00993 | DBMET00993 | |
| 0 | 0.96 | 0.036 | Egl nine homolog 3 inhibitor | 0.036 0.003 DBMET00993 | DBMET00993 | |
| 0.002 | 0.962 | 0.061 | Ryanodine receptor antagonist | 0.061 0.034 DBMET00993 | DBMET00993 | |
| 0.004 | 0.965 | 0.106 | Phosphodiesterase 6D inhibitor | 0.106 0.042 DBMET00993 | DBMET00993 | |
| 0.001 | 0.962 | 0.037 | RNA-directed RNA polymerase inhibitor | 0.037 0.021 DBMET00993 | DBMET00993 | |
| 0.001 | 0.962 | 0.024 | Thymidine phosphorylase inhibitor | 0.024 0.023 DBMET00993 | DBMET00993 | |
| 0.005 | 0.967 | 0.216 | Carbonic anhydrase III inhibitor | 0.216 0.014 DBMET00993 | DBMET00993 | |
| 0.002 | 0.963 | 0.272 | UDP-glucose 4-epimerase inhibitor | 0.272 0.012 DBMET00993 | DBMET00993 | |
| 0.009 | 0.971 | 0.136 | Amylase inhibitor | 0.136 0.071 DBMET00993 | DBMET00993 | |
| 0.002 | 0.965 | 0.173 | Carbonic anhydrase XV inhibitor | 0.173 0.024 DBMET00993 | DBMET00993 | |
| 0.001 | 0.963 | 0.195 | Nicotinic acid receptor agonist | 0.195 0.003 DBMET00993 | DBMET00993 | |
| 0.002 | 0.964 | 0.24 | Anesthetic general | 0.24 0.055 DBMET00993 | DBMET00993 | |
| 0.001 | 0.964 | 0.04 | CF transmembrane conductance regulator antagonist | 0.04 0.027 DBMET00993 | DBMET00993 | |
| 0.001 | 0.964 | 0.031 | HCV NS5B polymerase inhibitor | 0.031 0.022 DBMET00993 | DBMET00993 | |
| 0.001 | 0.964 | 0.109 | NMDA receptor glycine site agonist | 0.109 0.012 DBMET00993 | DBMET00993 | |
| 0.002 | 0.966 | 0.071 | Phosphodiesterase VI inhibitor | 0.071 0.059 DBMET00993 | DBMET00993 | |
| 0.002 | 0.966 | 0.248 | Creatine kinase inhibitor | 0.248 0.005 DBMET00993 | DBMET00993 | |
| 0.001 | 0.966 | 0.044 | Retinoid X alpha receptor antagonist | 0.044 0.011 DBMET00993 | DBMET00993 | |
| 0 | 0.965 | 0.076 | Fumarate hydratase inhibitor | 0.076 0.007 DBMET00993 | DBMET00993 | |
| 0.001 | 0.966 | 0.357 | Ferrochelatase inhibitor | 0.357 0.004 DBMET00993 | DBMET00993 | |
| 0.001 | 0.966 | 0.049 | Sphingosine 1-phosphate receptor agonist | 0.049 0.026 DBMET00993 | DBMET00993 | |
| 0 | 0.966 | 0.694 | Alcohol oxidase inhibitor | 0.694 0.003 DBMET00993 | DBMET00993 | |
| 0.004 | 0.969 | 0.043 | Nicotinic acid receptor 1 agonist | 0.043 0.025 DBMET00993 | DBMET00993 | |
| 0.001 | 0.967 | 0.05 | Retinoid X receptor antagonist | 0.05 0.012 DBMET00993 | DBMET00993 | |
| 0.003 | 0.97 | 0.062 | Topoisomerase II beta inhibitor | 0.062 0.021 DBMET00993 | DBMET00993 | |
| 0.001 | 0.967 | 0.095 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.095 0.018 DBMET00993 | DBMET00993 | |
| 0.003 | 0.97 | 0.433 | Aldehyde oxidase inhibitor | 0.433 0.042 DBMET00993 | DBMET00993 | |
| 0.002 | 0.969 | 0.208 | Mediator release inhibitor | 0.208 0.013 DBMET00993 | DBMET00993 | |
| 0.003 | 0.971 | 0.413 | Peroxidase inhibitor | 0.413 0.019 DBMET00993 | DBMET00993 | |
| 0 | 0.968 | 0.1 | Retinoid X receptor agonist | 0.1 0.005 DBMET00993 | DBMET00993 | |
| 0.006 | 0.975 | 0.274 | RNA-directed DNA polymerase inhibitor | 0.274 0.038 DBMET00993 | DBMET00993 | |
| 0 | 0.969 | 0.108 | Retinoid X alpha receptor agonist | 0.108 0.005 DBMET00993 | DBMET00993 | |
| 0.003 | 0.972 | 0.25 | Cyclic AMP phosphodiesterase inhibitor | 0.25 0.064 DBMET00993 | DBMET00993 | |
| 0.001 | 0.971 | 0.121 | Cytidine deaminase inhibitor | 0.121 0.099 DBMET00993 | DBMET00993 | |
| 0.001 | 0.972 | 0.241 | Prostaglandin EP1 antagonist | 0.241 0.004 DBMET00993 | DBMET00993 | |
| 0.003 | 0.973 | 0.126 | Purinergic P2X1 antagonist | 0.126 0.01 DBMET00993 | DBMET00993 | |
| 0 | 0.971 | 0.047 | Dihydropteroate synthase inhibitor | 0.047 0.019 DBMET00993 | DBMET00993 | |
| 0.001 | 0.972 | 0.048 | GABA receptor antagonist | 0.048 0.047 DBMET00993 | DBMET00993 | |
| 0 | 0.972 | 0.03 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.03 0.018 DBMET00993 | DBMET00993 | |
| 0.001 | 0.973 | 0.104 | GABA B receptor agonist | 0.104 0.014 DBMET00993 | DBMET00993 | |
| 0 | 0.973 | 0.036 | Phosphoglycerate kinase inhibitor | 0.036 0.023 DBMET00993 | DBMET00993 | |
| 0.001 | 0.974 | 0.071 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.071 0.005 DBMET00993 | DBMET00993 | |
| 0.002 | 0.975 | 0.161 | Electrolyte absorption antagonist | 0.161 0.016 DBMET00993 | DBMET00993 | |
| 0.007 | 0.981 | 0.376 | Calcium channel activator | 0.376 0.034 DBMET00993 | DBMET00993 | |
| 0.001 | 0.975 | 0.074 | Carbonic anhydrase VA inhibitor | 0.074 0.042 DBMET00993 | DBMET00993 | |
| 0.001 | 0.975 | 0.276 | Aryl hydrocarbon receptor agonist | 0.276 0.069 DBMET00993 | DBMET00993 | |
| 0.002 | 0.977 | 0.233 | 15-Lipoxygenase inhibitor | 0.233 0.18 DBMET00993 | DBMET00993 | |
| 0.002 | 0.977 | 0.133 | AMP-activated protein kinase stimulant | 0.133 0.039 DBMET00993 | DBMET00993 | |
| 0.001 | 0.976 | 0.108 | MAP kinase kinase 1 inhibitor | 0.108 0.047 DBMET00993 | DBMET00993 | |
| 0 | 0.976 | 0.041 | Free fatty acid receptor 1 antagonist | 0.041 0.015 DBMET00993 | DBMET00993 | |
| 0 | 0.976 | 0.082 | Urate transporter 1 inhibitor | 0.082 0.008 DBMET00993 | DBMET00993 | |
| 0.003 | 0.979 | 0.082 | Carbonic anhydrase VI inhibitor | 0.082 0.054 DBMET00993 | DBMET00993 | |
| 0.003 | 0.979 | 0.182 | DNA damaging | 0.182 0.132 DBMET00993 | DBMET00993 | |
| 0.002 | 0.979 | 0.099 | D-Ala-D-Ala ligase inhibitor | 0.099 0.03 DBMET00993 | DBMET00993 | |
| 0 | 0.977 | 0.059 | Carbonic anhydrase VB inhibitor | 0.059 0.036 DBMET00993 | DBMET00993 | |
| 0.001 | 0.977 | 0.067 | Carbonic anhydrase V inhibitor | 0.067 0.046 DBMET00993 | DBMET00993 | |
| 0.003 | 0.98 | 0.114 | DNA repair enzyme inhibitor | 0.114 0.086 DBMET00993 | DBMET00993 | |
| 0.002 | 0.979 | 0.198 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.198 0.074 DBMET00993 | DBMET00993 | |
| 0.004 | 0.982 | 0.033 | Purinergic P2Y2 antagonist | 0.033 0.024 DBMET00993 | DBMET00993 | |
| 0 | 0.978 | 0.118 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.118 0.011 DBMET00993 | DBMET00993 | |
| 0.002 | 0.98 | 0.152 | Aldehyde dehydrogenase inhibitor | 0.152 0.046 DBMET00993 | DBMET00993 | |
| 0 | 0.979 | 0.093 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.093 0.019 DBMET00993 | DBMET00993 | |
| 0.001 | 0.979 | 0.051 | Heparanase inhibitor | 0.051 0.041 DBMET00993 | DBMET00993 | |
| 0 | 0.979 | 0.208 | Biliverdin reductase inhibitor | 0.208 0.005 DBMET00993 | DBMET00993 | |
| 0.002 | 0.981 | 0.209 | NADH dehydrogenase inhibitor | 0.209 0.01 DBMET00993 | DBMET00993 | |
| 0.001 | 0.98 | 0.195 | Pyruvate kinase inhibitor | 0.195 0.084 DBMET00993 | DBMET00993 | |
| 0.003 | 0.983 | 0.194 | Hexokinase inhibitor | 0.194 0.039 DBMET00993 | DBMET00993 | |
| 0 | 0.98 | 0.076 | Kynurenine 3 monooxygenase inhibitor | 0.076 0.004 DBMET00993 | DBMET00993 | |
| 0 | 0.98 | 0.023 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.023 0.018 DBMET00993 | DBMET00993 | |
| 0.002 | 0.982 | 0.236 | Triose-phosphate isomerase inhibitor | 0.236 0.008 DBMET00993 | DBMET00993 | |
| 0.002 | 0.983 | 0.14 | NADPH oxidase inhibitor | 0.14 0.062 DBMET00993 | DBMET00993 | |
| 0.001 | 0.981 | 0.119 | Monophenol monooxygenase inhibitor | 0.119 0.062 DBMET00993 | DBMET00993 | |
| 0 | 0.981 | 0.191 | Xanthine dehydrogenase inhibitor | 0.191 0.005 DBMET00993 | DBMET00993 | |
| 0.001 | 0.982 | 0.202 | Cystathionine beta-synthase inhibitor | 0.202 0.024 DBMET00993 | DBMET00993 | |
| 0.001 | 0.982 | 0.125 | Alkaline phosphatase inhibitor | 0.125 0.081 DBMET00993 | DBMET00993 | |
| 0.001 | 0.983 | 0.075 | Carbonic anhydrase XIII inhibitor | 0.075 0.054 DBMET00993 | DBMET00993 | |
| 0 | 0.983 | 0.048 | Fructose-1,6-bisphosphatase inhibitor | 0.048 0.027 DBMET00993 | DBMET00993 | |
| 0 | 0.984 | 0.156 | Phenylalanine 4-hydroxylase inhibitor | 0.156 0.011 DBMET00993 | DBMET00993 | |
| 0.002 | 0.986 | 0.153 | Non-steroidal antiinflammatory agent | 0.153 0.111 DBMET00993 | DBMET00993 | |
| 0 | 0.984 | 0.033 | Uridine phosphorylase inhibitor | 0.033 0.015 DBMET00993 | DBMET00993 | |
| 0 | 0.985 | 0.074 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.074 0.057 DBMET00993 | DBMET00993 | |
| 0.001 | 0.988 | 0.25 | Hypoxia-inducible factor 1 alpha inhibitor | 0.25 0.101 DBMET00993 | DBMET00993 | |
| 0.001 | 0.988 | 0.236 | Xanthine oxidase inhibitor | 0.236 0.014 DBMET00993 | DBMET00993 | |
| 0 | 0.988 | 0.013 | Insulin like growth factor 3 antagonist | 0.013 0.002 DBMET00993 | DBMET00993 | |
| 0 | 0.989 | 0.172 | Mannose-6-phosphate isomerase inhibitor | 0.172 0.047 DBMET00993 | DBMET00993 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |